Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ïåäèàòðèÿ

Ïåäèàòðèÿ Ôîðóìû: Âàêöèíîïðîôèëàêòèêà, Ôîðóì äëÿ âðà÷åé ïåäèàòðîâ, ×àñòî çàäàâàåìûå âîïðîñû, Ïñèõîìîòîðíîå è ðå÷åâîå ðàçâèòèå äåòåé, Äåòñêî-ðîäèòåëüñêèå îòíîøåíèÿ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #31  
Ñòàðûé 05.02.2024, 21:09
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïî îïèñàíèþ áîëüøîãî ôèáðîçèðîâàíèÿ íåò, ïî ñðàâíåíèþ ñ äð. îòêëîíåíèÿìè, íå çíàþ êàê îíè åëàñòî-ìåòðèðóþò, íî ñòåïåíü ôèáðîçà ïî åòàñòî- ó âçðîñëîãî, ìîæåò áûòü ñîâñåì íå òî, ÷òî ó ãîäîâàñèêà - áèîïñèÿ çäåñü ãëàâíûé êðèòåðèé; ïîñìîòðèòå ñíèìîê ðåáåíêà â ïóáëèêàöèè, äëÿ åãîãî çíàíèå ÿçûêà íå íóæíî, ïîõîæè ëè îí ôåíîòèïè÷åñêè íà âàøåãî èëè íåò?
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #32  
Ñòàðûé 05.02.2024, 21:19
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
è åùå - ñòàòüÿ èç Ðîññèè, îíà íå ïðî âàø òèï áîëåçíè, íî ïðî ãëèêî-ãåíîçû â ÐÔ - öèòàòà îòòóäà - íî äëÿ âàñ âàæíû èìåíà è åìåéëû ëþäåé â ÐÔ êîòîðûå çàíèìàþòñÿ ýòèìè âîïðîñàìè íà ãåí. óðîâíå:

DNA samples of 93 Russian patients with a clinical diagnosis of hepatic GSD were collected and analyzed by next‐generation sequencing using a custom target panel and by direct sequencing in the Research Centre for Medical Genetics of Moscow from January 2016 until December 2017. Age of the patients varied from 0 to 16 years (median 3.5 years). The inclusion criteria were hypoglycemic episodes (glucose blood level < 3.3 mmol/L) or/and liver enlargement with or without cytolysis.

In 58 of 93 patients different GSDs were genetically confirmed. The GSD IXa was the most frequent and confirmed in 22 patients (23.7%).

äèàãíîç ãåíåòè÷åñêè áûë ïîäòâåðæä¸í â 60% ñëó÷àåâ, â 40% îñòàëüíûõ äèàãíîç íå áûë ïîäòâåðæäåò ãåíåòè÷åñêè (õîòÿ äèàãíîç ÍÅ èñêëþ÷åí è êëèíè÷åñêè è áèîïñèåé)

In seven patients from six unrelated families (four males and three females from 2 to 6 years old) alterations of the gene GYS2

10 different mutant alleles in GYS2 were identified. Three missense variants: c.116A>G.(Asn39Ser), c.1015G>C.(Ala339Pro) and c.1553A>C.(Glu518Ala) have been described and are classified in the Human Genetic Mutation Database (HGMD) as pathogenic (6, 10, 11). The other seven variants are novel: one frameshift deletion, two nonsense variants, and four missense substitutions

äåñÿòü ìóòàöèé íàøëè - èç íèõ ñåìü íîâûõ! - îòñóòñòâèå èçâåñòíûõ ìóòàöèé ó ðåáåíêà ÍÅ èñêëþ÷àåò äèàãíîçà!

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #33  
Ñòàðûé 05.02.2024, 21:24
Vika151087 Vika151087 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.02.2023
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 12
Vika151087 *
Ñåé÷àñ åìó óæå äâà è âîò òàêèõ áîëüøèõ ùåê ó íåãî íèêîãäà íå áûëî,íî ýòî íà ìîé âçãëÿä, ó íåãî î÷åíü äëèííûå ðåñíèöû,ìíå ïîýòîìó êàçàëîñü,÷òî èì âñåì ýòî íàïîìèíàåò êóêîëüíîå ëèöî. Âî âëîæåíèè ôîòî
Ìèíèàòþðû
Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: IMG_3854.jpeg
Ïðîñìîòðîâ: 30
Ðàçìåð:	863.7 Êá
ID:	251718  
Îòâåòèòü ñ öèòèðîâàíèåì
  #34  
Ñòàðûé 05.02.2024, 21:39
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ìíå ôîòî òàêèõ äåòåé íåèçâåñòíû, òàì ðåáåíêó 2-3 ìåñ., â âàøåé âûïèñêå åñòü îïèñàíèå ëèöà è ïðî øåêè òîæå, íî íè÷åãî ïðî ðåñíèöû èëè èõ äëèíó; Âàì íóæíà êîíñóëüòàöèÿ î÷íîãî ñïåöèàëèñòà, êîòîðûé âåë òàêèõ äåòåé è çíàåò êàê ñëîæèòü êëèíèêó è áèîõèìèþ â äèàãíîç, ìíå íåñïåöó èç-çà îêåàíà âèäíû ïîäîçðåíèÿ èìåííî íà òàêîé äèàãíîç, íåñìîòðÿ íà îòñóòñòâèå ãåí. ïîëîìîê, êîòîðûõ ìîæåò è íå áûòü â 40% ñëó÷àåâ
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #35  
Ñòàðûé 05.02.2024, 21:43
Vika151087 Vika151087 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.02.2023
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 12
Vika151087 *
Ñïàñèáî âàì.Ïîåäåì ñêîðî îïÿòü íà ãîñïèòàëèçàöèþ,áóäåì òàì äîáèâàòüñÿ îòâåòîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #36  
Ñòàðûé 05.02.2024, 21:47
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Older infants may exhibit certain physical characteristics,
such as doll-like facies with full cheeks and
relatively thin extremities along with
frequent lethargy, difficulty in waking from sleep, tremors, an insatiable appetite, growth retardation, and a prominent abdomen resulting from pronounced enlargement of the liver and kidneys. In some cases, xanthomas may appear on extensor surfaces, such as the elbows, knees, or buttocks. During an infection, symptoms of severe hypoglycemia are more prevalent owing to diminished appetite and/or gastrointestinal symptoms (e.g., vomiting and diarrhea) both preventing adequate oral intake. Delayed motor development can be seen but cognitive development is generally normal unless there is cerebral damage due to prolonged or recurrent neuroglycopenia.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #37  
Ñòàðûé 05.02.2024, 21:55
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âàì íå äîáèâàòüñÿ ãîñïèòàëèçàöèè íóæíî, à ïîíèìàíèå, êàê ñòàâèòñÿ äèàãíîç çà ðóáåæîì (ïåðåâîä íà ïðîñòîé ðóññêèé ôðàãìåíòîâ âûøå), è ïèñüìåííîå ïîäòâåðæäåíèå îò ïðîô. ñïåöèàëèñòà, ÷òîá öèòîëîã âçÿë ñòàòüþ, âçÿë ñòåêëî ðåáåíêà c áèîïòàòîì è íàïèñàë, ÷òî âîò åòî è òî êàê òàì íàïèñàíî õàðàêòåðíî äëÿ Ãà 1à, à íå 2á èëè åøå êàêîãî íîìåðà. À ëîæèòüñÿ â áîëüíèöó, ãäå íåò ñïåöèàëèñòîâ, êàê ëîæèòüñÿ ïîä áåñïëîäíîãî èìïîòåíòà, íàäåÿñü ÷òî ñ 10-ãî ðàçà ó íåãî òî÷íî âñå ïîëó÷èòñÿ è Âû òàêè çàáåðåìåíååòå.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #38  
Ñòàðûé 05.02.2024, 21:59
Vika151087 Vika151087 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.02.2023
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 12
Vika151087 *
Èç âñåãî îïèñàííîãî åñòü ïîâûøåííûé àïïåòèò,íî òîëüêî ê îïðåäåëåííûì ïðîäóêòàì,âñå ïîäðÿä åñòü íå áóäåò. Äèåòîëîã ïðîïèñàëà äèåòó ñ èñêëþ÷åíèåì ìîëî÷íîé ëàêòîçû,ñëèâî÷íîãî ìàñëà,ÿè÷íûõ æåëòêîâ. È äîáàâèëà áåëêîâûé ïîçäíèé óæèí ïåðåä ñíîì(òâîðîã ñ ôðóêòàìè èëè áåëîê îò ÿéöà). Êñàíòîì íà êîæå òîæå íå íàáëþäàëà,äà è âðà÷è íå àêöåíòèðîâàëè.Æèâîò ó íåãî êîíå÷íî óâåëè÷åí è íà åãî ôîíå ðóêè è íîãè ñìîòðÿòñÿ áîëåå õóäûìè. Ðîñò äåéñòâèòåëüíî ïî íèæíåé ãðàíèöû íîðìû,íî ó ìåíÿ ñóïðóã íèçêîãî ðîñòà,çäîðîâ. Ìû ïðîïèâàëè ãîä íàçàä êóðñ Ýëüêàðà (ëåâîêàðíèòèí),òîãäà ïîêàçàòåëè áûëè ëó÷øå. Ìîæåò è ñåé÷àñ ñòîèò åãî ïðîïèòü,áóäó óòî÷íÿòü òàêæå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #39  
Ñòàðûé 05.02.2024, 22:01
Vika151087 Vika151087 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.02.2023
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 12
Vika151087 *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
Âàì íå äîáèâàòüñÿ ãîñïèòàëèçàöèè íóæíî, à ïîíèìàíèå, êàê ñòàâèòñÿ äèàãíîç çà ðóáåæîì (ïåðåâîä íà ïðîñòîé ðóññêèé ôðàãìåíòîâ âûøå), è ïèñüìåííîå ïîäòâåðæäåíèå îò ïðîô. ñïåöèàëèñòà, ÷òîá öèòîëîã âçÿë ñòàòüþ, âçÿë ñòåêëî ðåáåíêà c áèîïòàòîì è íàïèñàë, ÷òî âîò åòî è òî êàê òàì íàïèñàíî õàðàêòåðíî äëÿ Ãà 1à, à íå 2á èëè åøå êàêîãî íîìåðà. À ëîæèòüñÿ â áîëüíèöó, ãäå íåò ñïåöèàëèñòîâ, êàê ëîæèòüñÿ ïîä áåñïëîäíîãî èìïîòåíòà, íàäåÿñü ÷òî ñ 10-ãî ðàçà ó íåãî òî÷íî âñå ïîëó÷èòñÿ è Âû òàêè çàáåðåìåíååòå.
 ýòîò ðàç ïîåäó ñî âñåìè âàøèìè ñòàòüÿìè,ó íàñ â îáëàñòè òî÷íî íåò òàêèõ ìîðôîëîãîâ,à òàì õî÷ó åùå îòäàòü áèîïñèþ íà ïåðåñìîòð. Ãîñïèòàëèçàöèÿ ó íàñ çàïëàíèðîâàíà íà ìàðò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #40  
Ñòàðûé 05.02.2024, 22:11
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ïðîñòèòå, íî âàì ñàìîé ïðèäåòñÿ ÷èòàòü êàê è ÷åì êîðìèòü ðåáåíêà ïðè äàííîé áîëåçíè, óëó÷øåíèÿ íà åëü-êàðå - åòî êàê ïîâûøåíèå çàðïëàòû ïîñëå âåñåííåãî ðàâíîäåíñòâèÿ - íàèâíûå âñåãäà ïóòàþò âðåìåííûå âçàèìîñâÿçè ñ ïðè÷èííî-ñëåäñòâåííûìè. Êàêîå áóäåò ó ðåáåíêà áóäóøåå (åñëè äèàãíîç ïîäòâåðäèòñÿ) çàâèñèò òîëüêî îò Âàñ, æäàòü ÷òî ïîìîæåò âàì ãîñóäàðñòâ. ìåäèöèíà íå ïðèõîäèòñÿ.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #41  
Ñòàðûé 05.02.2024, 22:15
Vika151087 Vika151087 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.02.2023
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 12
Vika151087 *
Öèòàòà:
Ñîîáùåíèå îò Dr.Vad Ïîñìîòðåòü ñîîáùåíèå
ïðîñòèòå, íî âàì ñàìîé ïðèäåòñÿ ÷èòàòü êàê è ÷åì êîðìèòü ðåáåíêà ïðè äàííîé áîëåçíè, óëó÷øåíèÿ íà åëü-êàðå - åòî êàê ïîâûøåíèå çàðïëàòû ïîñëå âåñåííåãî ðàâíîäåíñòâèÿ - íàèâíûå âñåãäà ïóòàþò âðåìåííûå âçàèìîñâÿçè ñ ïðè÷èííî-ñëåäñòâåííûìè. Êàêîå áóäåò ó ðåáåíêà áóäóøåå (åñëè äèàãíîç ïîäòâåðäèòñÿ) çàâèñèò òîëüêî îò Âàñ, æäàòü ÷òî ïîìîæåò âàì ãîñóäàðñòâ. ìåäèöèíà íå ïðèõîäèòñÿ.
Äà,÷åòêîãî ïîíèìàíèÿ ó ìåíÿ ïîêà íåò, ïîòîìó ÷òî âñå ÷òî ÿ ÷èòàëà ïðî ïèòàíèå ïðè ãëèêîãåíîçàõ âåçäå ðàçíèòñÿ. Ãäå-òî ïèøóò ïðî äèåòó ñ ïðåîáëàäàíèåì áåëêîâ,ãäå-òî óãëåâîäîâ. Íî ðåáåíêà î÷åíü ñëîæíî âîîáùå ÷åì òî íàêîðìèòü. Åñëè åùå è ôðóêòû èñêëþ÷àòü( à ãäå òî ÿ ÷èòàëà è ïðî èñêëþ÷åíèå ôðóêòîçû,à íå òîëüêî ñàõàðîçû,òî áîþñü îí âîîáùå åñòü ïåðåñòàíåò)🤦🏼♀
Îòâåòèòü ñ öèòèðîâàíèåì
  #42  
Ñòàðûé 05.02.2024, 22:16
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
îñòàâëþ Âàì êàê ðóêîâîäñòâî ê äåéñòâèþ íà áëèæàéøåå âðåìÿ: çà ýòîò ìåñÿö äîñëîâíî ïåðåâåäèòå íà ïîíÿòíûé ðóññêèé ÂÑÞ äèàãíîñòè÷åñêóþ ÷àñòü, åñëè ä-ç ïîäòâåðäèòñÿ - òàì è ïî âåäåíèþ ðåáåíêà (íå çíàþ, íóæíî ëè ñåé÷àñ)

Diagnosis and management of glycogen storage disease type I:
a practice guideline of the American College of Medical Genetics and Genomics

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #43  
Ñòàðûé 05.02.2024, 22:18
Vika151087 Vika151087 âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 08.02.2023
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 34
Ñêàçàë(à) ñïàñèáî: 12
Vika151087 *
Ñïàñèáî âàì áîëüøîå! Áóäó òóò ïèñàòü îá óñïåõàõ èëè íåóäà÷àõ â íàøèõ ïîèñêàõ 😔
Îòâåòèòü ñ öèòèðîâàíèåì
  #44  
Ñòàðûé 06.02.2024, 19:42
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
íåáîëüøàÿ ïîïðàâêà, â îòðåçàííîì ôðàãìåíòå èç áèîïñèè ðåáåíêà âíèçó èìååòñÿ áîëüøå äàííûõ çà 3-èé òèï, a íå ïåðâûé - òîãäà è ôèáðîç ïîíÿòåí, âûäåëþ àíàëîãèþ íà àíãëèéñêîì:

By contrast, in most patients with GSD III, the liver biopsy demonstrates a vacuolar accumulation of non–membrane bound glycogen primarily located in the cytoplasm. Lipid vacuoles are far less numerous in GSD III than in GSD I. The presence of fibrosis, ranging from minimal periportal fibrosis to micronodular cirrhosis, occurs in GSD III, but not in GSD I. Periportal fibrosis is a very early finding in GSD III. In GSD III, the stored material is within the cytoplasm, periodic acid schiff positive, and diastase sensitive.
Ìèíèàòþðû
Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: Untitled.png
Ïðîñìîòðîâ: 2
Ðàçìåð:	414.9 Êá
ID:	251762  
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #45  
Ñòàðûé 06.02.2024, 20:42
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,391
Ïîáëàãîäàðèëè 33,235 ðàç(à) çà 31,584 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
òðåòèé òèï åùå áîëåå ðåäêîå çàáîëåâàíèå è ïîäðàçäåëÿåòñÿ íà ïîäòèïû ñ ïîðàæåíèåì òîëüêî ïå÷åíè èëè ïå÷åíü ïëþñ ìûøöû ïëþñ ñåðäöå - âðîäå áû êàê åñëè ÊÔÊ â íîðìå, òî ýòî íå ìûøå÷íàÿ ôîðìà, à òîëüêî ïå÷åíî÷íàÿ:

Serum CK levels can be useful to identify individuals with muscle involvement; however, normal CK levels do not rule out muscle enzyme deficiency.

îñòàâëþ çäåñü ðåêîìåíäàöèè èç øòàòîâ è ôðàíöèè

French recommendations for the management of glycogen storage disease type III
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Glycogen Storage Disease Type III diagnosis and management guidelines
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 14:22.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.